Inventor · disambiguated record
Alan David Borthwick
Also filed as: BORTHWICK ALAN · BORTHWICK ALAN D · BORTHWICK ALAN DAVID
31 granted patents·11 pending applications·155 citations·filing 1983–2022
96Inventor score
Top patents by PatentIndex Score
42 records- 0193US7919492B2CompoundsGLAXO GROUP LTD·Filed 2010·Granted Apr 5, 2011·13 cites·4 claims
- 0293US7550462B2Piperazinediones as oxytocin receptor antagonistsGLAXO GROUP LTD·Filed 2005·Granted Jun 23, 2009·15 cites·6 claims
- 0391US9408851B2CompoundsGLAXO GROUP LTD·Filed 2015·Granted Aug 9, 2016·6 cites·2 claims
- 0489US8742099B2CompoundsGLAXO GROUP LTD·Filed 2013·Granted Jun 3, 2014·7 cites·1 claims
- 0589US8202864B2CompoundsBORTHWICK ALAN DAVID·Filed 2011·Granted Jun 19, 2012·11 cites·4 claims
- 0688US10385044B2Bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (RARβ) agonistsKING S COLLEGE LONDON·Filed 2018·Granted Aug 20, 2019·6 cites·38 claims
- 0785US9994559B2Bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (RARβ) agonistsKING S COLLEGE LONDON·Filed 2015·Granted Jun 12, 2018·5 cites·30 claims
- 0885US8367673B2Substituted diketopiperazines as oxytocin antagonistsGLAXO GROUP LTD·Filed 2009·Granted Feb 5, 2013·8 cites·11 claims
- 0983US11401265B2Bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (RARβ) agonistsKING S COLLEGE LONDON·Filed 2020·Granted Aug 2, 2022·1 cites·26 claims
- 1083US8541579B2Substituted diketopiperazines as oxytocin antagonistsGLAXO GROUP LTD·Filed 2012·Granted Sep 24, 2013·6 cites·1 claims
- 1181US7514437B2Substituted diketopiperazines as oxytocin antagonistsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Apr 7, 2009·15 cites·12 claims
- 1280US10752616B2Bicycloheteroaryl-heteroaryl-benzoic acid compounds as retinoic acid receptor beta (RARβ) agonistsKING S COLLEGE LONDON·Filed 2019·Granted Aug 25, 2020·2 cites·28 claims
- 1373US5155112ACyclopentane derivativesGLAXO GROUP LTD·Filed 1990·Granted Oct 13, 1992·15 cites·20 claims
- 1470US10870644B2Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-l,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparationKING S COLLEGE LONDON·Filed 2017·Granted Dec 22, 2020·1 cites·14 claims
- 1570US9447028B2Therapeutic aryl-amido-aryl compounds and their useKING S COLLEGE LONDON·Filed 2015·Granted Sep 20, 2016·1 cites·20 claims
- 1667US2009247541A1Novel compoundsBORTHWICK ALAN DAVID·Filed 2009·Application pending·0 cites
- 1766US7179835B22-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitorsGLAXO GROUP LTD·Filed 2002·Granted Feb 20, 2007·3 cites·10 claims
- 1866US4496579ABenzodioxinopyrrole derivatives and processes for their preparationGLAXO GROUP LTD·Filed 1983·Granted Jan 29, 1985·11 cites·11 claims
- 1966US2014235639A1Novel compoundsGLAXO GROUP LTD·Filed 2014·Application pending·0 cites
- 2063US11584741B2Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-1,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparationKING S COLLEGE LONDON·Filed 2020·Granted Feb 21, 2023·0 cites·13 claims
- 2161US7329685B21-Phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor Xa inhibitors for the treatment of acute vascular diseasesGLAXO GROUP LTD·Filed 2004·Granted Feb 12, 2008·1 cites·8 claims
- 2260US4769367AHeterocyclic amino compoundsGLAXO GROUP LTD·Filed 1986·Granted Sep 6, 1988·6 cites·9 claims
- 2359US2012202811A1Novel compoundsBORTHWICK ALAN DAVID·Filed 2012·Application pending·0 cites
- 2458US7235544B23-sulfonylamino-pyrrolidine-2-one derivatives as inhibitors of factor XaGLAXO GROUP LTD·Filed 2004·Granted Jun 26, 2007·1 cites·8 claims
- 2558US2015157640A1Novel compoundsGLAXO GROUP LTD·Filed 2015·Application pending·0 cites
- 2649US4880801AHeterocyclic amino compoundsGLAXO GROUP LTD·Filed 1988·Granted Nov 14, 1989·6 cites·15 claims
- 2749US4806533A1,4-Dihydro pyridine 3,5 dicarboxylic acid derivatives and compositionsGLAXO SPA·Filed 1987·Granted Feb 21, 1989·4 cites·19 claims
- 2847US7482374B2Pyrrolidine-2-ones as Factor Xa inhibitorsGLAXO GROUP LTD·Filed 2004·Granted Jan 27, 2009·0 cites·9 claims
- 2946US2024190809A1Therapeutic aminoindane compounds and compositionsAWAKN LS EUROPE HOLDINGS LTD·Filed 2022·Application pending·0 cites
- 3044US2007203206A12-Pyrrolidone Derivatives And Use Thereof As Factor Xa InhibitorsBORTHWICK ALAN D·Filed 2004·Application pending·0 cites
- 3143US2006166985A1Pyrrolydin-2-one derivatives as inhibitors of thrombin and factor xaBORTHWICK ALAN D·Filed 2003·Application pending·0 cites
- 3242US2012149737A1Therapeutic Aryl-Amido-Aryl Compounds and Their UseCORCORAN JONATHAN PATRICK THOMAS·Filed 2010·Application pending·0 cites
- 3341US5162345AHeterocyclic compounds and their preparation and pharmaceutical formulationGLAXO SPA·Filed 1990·Granted Nov 10, 1992·4 cites·19 claims
- 3441US4963571APyridinedicarboxylic acid derivatives and pharmaceutical compositionsGLAXO SPA·Filed 1988·Granted Oct 16, 1990·2 cites·19 claims
- 3540US2007185162A1Substituted diketopiperazines as oxytocin receptor antagonistsKONINKL PHILIPS ELECTRONICS NV·Filed 2005·Application pending·0 cites
- 3639US4946851A1.4-dihydropyridinesGLAXO SPA·Filed 1988·Granted Aug 7, 1990·2 cites·18 claims
- 3739US2005059726A1Pyrrolidine-2-ones as factor xa inhibitorsFiled 2002·Application pending·0 cites
- 3839US2007208031A1Substituted Diketopiperazines as Oxytocin AntagonistsBORTHWICK ALAN D·Filed 2005·Application pending·0 cites
- 3934US4935548A1.4-dihydropyridinesGLAXO SPA·Filed 1988·Granted Jun 19, 1990·1 cites·19 claims
- 4032US5100896ACarbocyclic analogues of 7H-1,2,3-triazolo [4,5-d]pyrimidine furanosidesGLAXO GROUP LTD·Filed 1990·Granted Mar 31, 1992·1 cites·9 claims
- 4132US5091395AHeterocyclic compounds and their pharmaceutical formulationGLAXO SPA·Filed 1988·Granted Feb 25, 1992·0 cites·18 claims
- 4232US5051432AHeterocyclic 1,4 dihydropyridine derivativesGLAXO SPA·Filed 1990·Granted Sep 24, 1991·1 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Alan David Borthwick files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →